IDEAYA Biosciences, Inc.
NASDAQ:IDYA
18.96 (USD) • At close March 13, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 7 | 0 | 0 | 0 | 3.923 | 8.038 | 3.544 | 7.88 | 4.022 | 29.699 | 5.851 | 11.359 | 2.963 | 8.976 | 8.756 | 7.247 | 10.571 | 8.967 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 0 | 1.097 | 1.082 | 1.024 | 0.986 | 0.998 | 0.96 | 0.558 | 0.925 | 1.204 | 0.464 | 0.425 | 15.503 | 14.979 | 11.566 | 12.051 | 10.025 | 8.596 | 9.026 | 8.541 | 8.923 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 7 | 0 | -1.097 | -1.082 | 2.899 | 7.052 | 2.546 | 6.92 | 3.464 | 28.774 | 4.647 | 10.895 | 2.538 | -6.527 | -6.223 | -4.319 | -1.48 | -1.058 | -8.596 | -9.026 | -8.541 | -8.923 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 1 | 0 | 0 | 0 | 0.739 | 0.877 | 0.718 | 0.878 | 0.861 | 0.969 | 0.794 | 0.959 | 0.857 | -0.727 | -0.711 | -0.596 | -0.14 | -0.118 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 140.183 | 57.152 | 54.533 | 42.805 | 38.77 | 33.701 | 29.178 | 27.859 | 24.714 | 22.372 | 22.796 | 19.656 | 16.109 | 15.503 | 14.979 | 11.566 | 12.051 | 10.024 | 8.596 | 9.026 | 8.541 | 8.923 | 8.859 | 7.996 | 7.577 | 12.538 | 6.432 | 5.202 |
| General & Administrative Expenses
| 10.955 | 9.741 | 10.394 | 8.212 | 7.069 | 7.863 | 7.075 | 6.3 | 5.752 | 6.667 | 5.554 | 5.923 | 5.223 | 5.186 | 4.828 | 4.816 | 3.8 | 3.939 | 3.994 | 3.452 | 2.778 | 2.7 | 2.376 | 2.098 | 1.556 | 1.088 | 1.139 | 0.885 |
| Selling & Marketing Expenses
| 0 | 0 | -1.097 | 0 | -0.001 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 10.955 | 9.741 | 9.297 | 8.212 | 7.068 | 7.863 | 7.075 | 6.3 | 5.752 | 6.667 | 5.554 | 5.923 | 5.223 | 5.186 | 4.828 | 4.816 | 3.8 | 3.939 | 3.994 | 3.452 | 2.778 | 2.7 | 2.376 | 2.098 | 1.556 | 1.088 | 1.139 | 0.885 |
| Other Expenses
| 0 | 0 | -54.533 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4.423 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.002 | 0 | 0.006 | 0 | 0 | 0.001 | 0.008 | 0.068 |
| Operating Expenses
| 151.138 | 66.893 | 63.83 | 51.017 | 45.838 | 41.564 | 36.253 | 34.159 | 30.466 | 29.039 | 28.35 | 25.579 | 21.332 | 20.689 | 19.807 | 16.382 | 15.851 | 13.963 | 12.59 | 12.478 | 11.319 | 11.623 | 11.235 | 10.094 | 9.133 | 13.626 | 7.571 | 6.087 |
| Operating Income
| -144.138 | -66.893 | -64.927 | -51.017 | -41.915 | -33.526 | -32.709 | -26.279 | -26.444 | 0.66 | -22.499 | -14.22 | -18.369 | -11.713 | -11.051 | -9.135 | -5.28 | -4.996 | -12.59 | -12.478 | -11.319 | -11.623 | -11.235 | -10.094 | -9.133 | -13.626 | -7.571 | -6.087 |
| Operating Income Ratio
| -20.591 | 0 | 0 | 0 | -10.684 | -4.171 | -9.229 | -3.335 | -6.575 | 0.022 | -3.845 | -1.252 | -6.199 | -1.305 | -1.262 | -1.261 | -0.499 | -0.557 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 13.826 | 15.072 | 12.155 | 11.445 | 7.96 | 6.086 | 4.783 | 2.639 | 2.242 | 0.955 | 0.443 | 0.207 | 0.157 | 0.131 | 0.104 | 0.114 | 0.145 | 0.07 | 0.199 | 0.435 | 0.538 | 0.654 | 0.579 | 0.525 | 0.571 | 0.574 | 0.576 | 0.35 |
| Income Before Tax
| -130.312 | -51.821 | -52.772 | -39.572 | -33.955 | -27.44 | -27.926 | -23.64 | -24.201 | 1.615 | -22.056 | -16.105 | -18.212 | -11.582 | -10.947 | -9.021 | -5.135 | -4.926 | -12.391 | -12.043 | -10.781 | -10.969 | -10.656 | -9.569 | -8.562 | -13.052 | -6.995 | -5.737 |
| Income Before Tax Ratio
| -18.616 | 0 | 0 | 0 | -8.655 | -3.414 | -7.88 | -3 | -6.017 | 0.054 | -3.77 | -1.418 | -6.146 | -1.29 | -1.25 | -1.245 | -0.486 | -0.549 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0 | 0 | -1.082 | 5.623 | -1.026 | -0.998 | -3.599 | -2.242 | -0.955 | -0.443 | 1.885 | -20.125 | -19.968 | 0.044 | 0 | 4.769 | -0.347 | 0 | 0 | -0.866 | 0 | -0.573 | 0 | 0 | -0.573 | -0.568 | -0.282 |
| Net Income
| -130.312 | -51.821 | -52.772 | -39.572 | -33.955 | -27.44 | -27.926 | -20.041 | -21.959 | 2.57 | -21.613 | -17.99 | -18.212 | -11.582 | -10.947 | -9.021 | -5.135 | -4.926 | -12.391 | -12.043 | -10.781 | -10.969 | -10.656 | -9.569 | -8.562 | -13.052 | -6.995 | -5.737 |
| Net Income Ratio
| -18.616 | 0 | 0 | 0 | -8.655 | -3.414 | -7.88 | -2.543 | -5.46 | 0.087 | -3.694 | -1.584 | -6.146 | -1.29 | -1.25 | -1.245 | -0.486 | -0.549 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -1.6 | -0.6 | -0.68 | -0.53 | -0.52 | -0.46 | -0.5 | -0.41 | -0.46 | 0.064 | -0.56 | -0.47 | -0.47 | -0.31 | -0.33 | -0.28 | -0.18 | -0.17 | -0.59 | -0.59 | -0.53 | -0.54 | -0.54 | -0.49 | -0.6 | -0.92 | -0.49 | -0.4 |
| EPS Diluted
| -1.6 | -0.6 | -0.68 | -0.53 | -0.52 | -0.46 | -0.5 | -0.41 | -0.46 | 0.063 | -0.56 | -0.47 | -0.47 | -0.31 | -0.33 | -0.28 | -0.18 | -0.17 | -0.59 | -0.59 | -0.53 | -0.54 | -0.54 | -0.49 | -0.6 | -0.92 | -0.49 | -0.4 |
| EBITDA
| -143.495 | -66.893 | -64.305 | -50.401 | -41.288 | -32.886 | -32.09 | -25.691 | -25.885 | 1.585 | -21.639 | -13.756 | -17.787 | -11.262 | -10.607 | -8.753 | -4.919 | -4.649 | -12.253 | -12.142 | -10.989 | -11.299 | -10.937 | -9.801 | -8.87 | -13.403 | -7.364 | -5.894 |
| EBITDA Ratio
| -20.499 | 0 | 0 | 0 | -10.424 | -4.171 | -9.229 | -3.335 | -6.575 | 0.053 | -3.64 | -1.027 | -6.199 | -1.255 | -1.211 | -1.208 | -0.499 | -0.557 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |